Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
5.85
-0.05 (-0.85%)
At close: Nov 5, 2026, 4:00 PM EST
5.76
-0.09 (-1.54%)
After-hours: Nov 5, 2026, 7:30 PM EST

Emergent BioSolutions Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
175.7205.499.5111.7642.6576.1
Trading Asset Securities
----8.5-
Cash & Short-Term Investments
175.7205.499.5111.7651.1576.1
Cash Growth
-28.43%106.43%-10.92%-82.84%13.02%-7.27%
Accounts Receivable
77.584.2154.5191159.2278.9
Receivables
77.584.2154.5191159.2278.9
Inventory
280.9343.4311.7328.9350.7344.5
Prepaid Expenses
22.925.826.947.949.468.2
Restricted Cash
1.23.76.1--0.2
Other Current Assets
-----2
Total Current Assets
558.2662.5598.7679.51,2101,270
Property, Plant & Equipment
180.2216282.3399837828.4
Goodwill
----218.2224.9
Other Intangible Assets
252.5436.5501.5566.6728.8604.6
Long-Term Deferred Charges
-----1.6
Other Long-Term Assets
4.33.67.2178.1171.928.3
Total Assets
995.21,3191,3901,8233,1662,958

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5255.660.9112.2103.5128.9
Accrued Expenses
41.65473.892.7122.2140.4
Current Portion of Long-Term Debt
---413.7957.336.1
Current Portion of Leases
1.52.42.73.55.85.8
Current Income Taxes Payable
4.36.85.8---
Current Unearned Revenue
14.354.827.226.411.7
Other Current Liabilities
8.38.414.4213.751.1
Total Current Liabilities
122132.2162.4651.31,229374
Long-Term Debt
507.7572.1663.7446.5448.5811
Long-Term Leases
4.59.29.713.814.824.2
Long-Term Deferred Tax Liabilities
22.237.841.747.259.793.3
Other Long-Term Liabilities
25.644.729.415.126.743.7
Total Liabilities
682796906.91,1741,7791,346

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.10.10.10.10.10.1
Additional Paid-In Capital
956.6942.4928904.4873.5829.4
Retained Earnings
-365.9-159.8-212.4-21.8738.7950.3
Treasury Stock
-270.7-252.6-227.7-227.7-227.7-152.2
Comprehensive Income & Other
-6.9-7.5-5.2-5.73.1-16.1
Shareholders' Equity
313.2522.6482.8649.31,3881,612
Total Liabilities & Equity
995.21,3191,3901,8233,1662,958

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
513.7583.7676.1877.51,426877.1
Net Cash (Debt)
-338-378.3-576.6-765.8-775.3-301
Net Cash Growth
------
Net Cash Per Share
-6.53-6.67-10.88-14.96-15.48-5.56
Filing Date Shares Outstanding
51.4251.7754.3452.250.1450.5
Total Common Shares Outstanding
51.352.1354.3352.250.151.3
Working Capital
436.2530.3436.328.2-18.5895.9
Book Value Per Share
6.1110.028.8912.4427.7031.41
Tangible Book Value
60.786.1-18.782.7440.7782
Tangible Book Value Per Share
1.181.65-0.341.588.8015.24
Land
16.520.725.83054.952.1
Buildings
140.6160.5196.1229.9327.9269.7
Machinery
248.4259.8368.3433.6567.5513.5
Construction In Progress
7.26.610.336.7185.5223.2
SEC Filings: 10-K · 10-Q